Clinical Trial Update: Clinical Trial to Study the Safety and Effectiveness of MK0826 and Other Antibiotic Therapy in Patients With Complicated Urinary Tract Infection (0826-054) [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating MK0826 with other antibiotic therapy for complicated urinary tract infections was terminated, and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urinary Tract Infection

Drugs mentioned

• MK0826

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Urinary Tract Infections | Phase 3 | Status: TERMINATED | Results posted: 2010-07-09